The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
TIL Therapy-Global Market Insights and Sales Trends 2024
Synopsis
The global TIL Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TIL Therapy in various end use industries. The expanding demands from the Stomach Cancer, Cancer of Pancreas, Hepatoma and Uterine/Endometrial Carcinoma, are propelling TIL Therapy market. Single Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multiple Injections segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for TIL Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the TIL Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TIL Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TIL Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TIL Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TIL Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TIL Therapy covered in this report include Lovance, MacroGenics, TILT Biotherapeutics, Genocea, Orgenesis, Cellectis, Lonza, Lytix Biopharma and PolyBioCept AB, etc.
The global TIL Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lovance
MacroGenics
TILT Biotherapeutics
Genocea
Orgenesis
Cellectis
Lonza
Lytix Biopharma
PolyBioCept AB
Global TIL Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TIL Therapy market, Segment by Type:
Single Injection
Multiple Injections
Global TIL Therapy market, by Application
Stomach Cancer
Cancer of Pancreas
Hepatoma
Uterine/Endometrial Carcinoma
Cervical Carcinoma
Urethral Carcinoma
Renal-cell Carcinoma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TIL Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global TIL Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of TIL Therapy in various end use industries. The expanding demands from the Stomach Cancer, Cancer of Pancreas, Hepatoma and Uterine/Endometrial Carcinoma, are propelling TIL Therapy market. Single Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multiple Injections segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for TIL Therapy market, driven by demand from China, the second largest economy with some signs of stabilising, the TIL Therapy market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for TIL Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global TIL Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global TIL Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, TIL Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of TIL Therapy covered in this report include Lovance, MacroGenics, TILT Biotherapeutics, Genocea, Orgenesis, Cellectis, Lonza, Lytix Biopharma and PolyBioCept AB, etc.
The global TIL Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lovance
MacroGenics
TILT Biotherapeutics
Genocea
Orgenesis
Cellectis
Lonza
Lytix Biopharma
PolyBioCept AB
Global TIL Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global TIL Therapy market, Segment by Type:
Single Injection
Multiple Injections
Global TIL Therapy market, by Application
Stomach Cancer
Cancer of Pancreas
Hepatoma
Uterine/Endometrial Carcinoma
Cervical Carcinoma
Urethral Carcinoma
Renal-cell Carcinoma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of TIL Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of TIL Therapy
1.1 TIL Therapy Market Overview
1.1.1 TIL Therapy Product Scope
1.1.2 TIL Therapy Market Status and Outlook
1.2 Global TIL Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global TIL Therapy Market Size by Region (2018-2029)
1.4 Global TIL Therapy Historic Market Size by Region (2018-2023)
1.5 Global TIL Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, TIL Therapy Market Size (2018-2029)
1.6.1 North America TIL Therapy Market Size (2018-2029)
1.6.2 Europe TIL Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific TIL Therapy Market Size (2018-2029)
1.6.4 Latin America TIL Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa TIL Therapy Market Size (2018-2029)
2 TIL Therapy Market by Type
2.1 Introduction
2.1.1 Single Injection
2.1.2 Multiple Injections
2.2 Global TIL Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global TIL Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global TIL Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America TIL Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe TIL Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific TIL Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America TIL Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa TIL Therapy Revenue Breakdown by Type (2018-2029)
3 TIL Therapy Market Overview by Application
3.1 Introduction
3.1.1 Stomach Cancer
3.1.2 Cancer of Pancreas
3.1.3 Hepatoma
3.1.4 Uterine/Endometrial Carcinoma
3.1.5 Cervical Carcinoma
3.1.6 Urethral Carcinoma
3.1.7 Renal-cell Carcinoma
3.1.8 Other
3.2 Global TIL Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global TIL Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global TIL Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America TIL Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe TIL Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific TIL Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America TIL Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa TIL Therapy Revenue Breakdown by Application (2018-2029)
4 TIL Therapy Competition Analysis by Players
4.1 Global TIL Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TIL Therapy as of 2022)
4.3 Date of Key Players Enter into TIL Therapy Market
4.4 Global Top Players TIL Therapy Headquarters and Area Served
4.5 Key Players TIL Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 TIL Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lovance
5.1.1 Lovance Profile
5.1.2 Lovance Main Business
5.1.3 Lovance TIL Therapy Products, Services and Solutions
5.1.4 Lovance TIL Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Lovance Recent Developments
5.2 MacroGenics
5.2.1 MacroGenics Profile
5.2.2 MacroGenics Main Business
5.2.3 MacroGenics TIL Therapy Products, Services and Solutions
5.2.4 MacroGenics TIL Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 MacroGenics Recent Developments
5.3 TILT Biotherapeutics
5.3.1 TILT Biotherapeutics Profile
5.3.2 TILT Biotherapeutics Main Business
5.3.3 TILT Biotherapeutics TIL Therapy Products, Services and Solutions
5.3.4 TILT Biotherapeutics TIL Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Genocea Recent Developments
5.4 Genocea
5.4.1 Genocea Profile
5.4.2 Genocea Main Business
5.4.3 Genocea TIL Therapy Products, Services and Solutions
5.4.4 Genocea TIL Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Genocea Recent Developments
5.5 Orgenesis
5.5.1 Orgenesis Profile
5.5.2 Orgenesis Main Business
5.5.3 Orgenesis TIL Therapy Products, Services and Solutions
5.5.4 Orgenesis TIL Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Orgenesis Recent Developments
5.6 Cellectis
5.6.1 Cellectis Profile
5.6.2 Cellectis Main Business
5.6.3 Cellectis TIL Therapy Products, Services and Solutions
5.6.4 Cellectis TIL Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Cellectis Recent Developments
5.7 Lonza
5.7.1 Lonza Profile
5.7.2 Lonza Main Business
5.7.3 Lonza TIL Therapy Products, Services and Solutions
5.7.4 Lonza TIL Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Lonza Recent Developments
5.8 Lytix Biopharma
5.8.1 Lytix Biopharma Profile
5.8.2 Lytix Biopharma Main Business
5.8.3 Lytix Biopharma TIL Therapy Products, Services and Solutions
5.8.4 Lytix Biopharma TIL Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Lytix Biopharma Recent Developments
5.9 PolyBioCept AB
5.9.1 PolyBioCept AB Profile
5.9.2 PolyBioCept AB Main Business
5.9.3 PolyBioCept AB TIL Therapy Products, Services and Solutions
5.9.4 PolyBioCept AB TIL Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 PolyBioCept AB Recent Developments
6 North America
6.1 North America TIL Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe TIL Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific TIL Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America TIL Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa TIL Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 TIL Therapy Market Dynamics
11.1 TIL Therapy Industry Trends
11.2 TIL Therapy Market Drivers
11.3 TIL Therapy Market Challenges
11.4 TIL Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
